The Division of Medical Screening and Special Testing, part of the Department of Pathology and Laboratory Medicine, offers specialized laboratory testing in prenatal screening, reproductive endocrinology, and women's health, with the highest quality, rapid turnaround and reasonable cost.
From research to clinical practice, our laboratory has developed both a national and international reputation in these areas of testing. We were involved in the development of, and were the first academic program in the U.S. to offer the triple and then the Quad test for prenatal screening. We also served as the central laboratory in the FASTER Trial, a large-scale, national intervention trial sponsored by the NIH to compare first and second trimester screening methods. We have now implemented a new generation of screening tests, including the full and serum Integrated and the First Trimester Combined Test.
Our laboratory is among the most experienced in the U.S. in the measurement of inhibin A, inhibin B and related proteins, and was the first to report on the use of inhibin types in prenatal screening and testing for ovarian reserve.
- Prenatal screening
- AFP PLUS Quad Test, Full and Serum Integrated Test, First Trimester Test, PAPP-A, inhibin A, amniotic fluid AFP, AChE and HbF
- hCG, LH, FSH, prolactin, inhibin B estradiol, progesterone, testosterone, DHEA sulfate, AMH
- Tumor markers
- CA125, CA15-3, CEA, hCG, AFP, PSA, inhibin B, HE4
- Thyroid function
- TSH, TT4, FT4, T uptake, TSH in pregnancy